CLINICAL LAB SCIENEC

462
INDEX
American Society of Clinical Pathologists
(ASCP), 8, 14, 17,
37, 53, 54
Board of Registry, 23
on phlebotomy programs, 268
American Society of Clinical
Pathologists (ASCP) registry
examination, 10
Americans with Disabilities Act
(ADA), 12
Ammonium biurate crystals, 307f
AMTs. See American Medical
Technologists (AMTs)
Analysis(es)
centrifugal, 365
discrete, 365
sequential, 354, 365
Analyte(s), 364
defined, 237
Analytical error, 258–259
defined, 235t
Analytical variation, 260
Anatomic pathologists, described,
28–29, 29f
Anatomic pathology, 79
Anatomical positioning, effects on
laboratory values, 257
Anemia, 208
sickle cell, sickle-shaped cells in,
350f
Anion(s), 381
Anti-A sera, ABO blood group
reactions with, 418, 418t
Anti-B sera, ABO blood group
reactions with, 418, 418t
Antibody(ies), atypical, 417
Antibody-antigen reactions, 81–82
Antigen(s), 401
D, 428
described, 83
Antinuclear antibody test, 411
Antispermatic preparations, in urine,
301
APTT. See Activated partial thromboplastin
time (APTT)
Artery(ies), defined, 266
Artifact(s), in urine sediment, 308,
308f
ASCLS. See American Society for
Clinical Laboratory Scientists
(ASCLS)
ASCP. See American Society of Clinical
Pathologists (ASCP)
ASCP registry examination. See
American Society of Clinical
Pathologists (ASCP) registry
examination
Assay(s), radioimmune, 416
Assay conditions, 227, 227t
Assayed controls, defined, 245–246
Association of Surgical Technologists
(AST), 35
AST. See Association of Surgical
Technologists (AST)
AST/GOT, determination of,
378–381, 379f. See also Serum
asparate aminotransferase
(AST), determination of
Atypical antibodies, 417
Autoantibodies, 418
Autoimmune diseases, 402
Automated testing, 181–182
Automation, in chemistry laboratory,
366
Average, for laboratory test, defined,
235t
B
Bacillus Calmette-Guérin (BCG), in
TB prevention, 144
Bacon, R., in history of laboratory
medicine, 6, 7t
Bacteria, 305f
contamination by, 282
resistant strains of, 388–389
Bacterial colonies, isolation of,
streaking for, 393, 393f
Bacterial incinerator, 388, 389f
Bacterial infections, sources of, 391
Baer, D.M., 165
Baseline determinations, 131
Baseline sample, 127
Basilic vein, defined, 266
Basophils, 330t
Bayer Multistix 10 SG, color graph
for, 293, 293f
BCG. See Bacillus Calmette-Guérin
(BCG)
Beadle, G.W., in history of laboratory
medicine, 8
Beaker(s), Griffin, 189, 190f
Beer’s law, 225–226, 226f
“Bench tech,” 32
Beral pipettes, 198, 198f, 199
Bevel, defined, 266
Bilirubin, in urine, semiquantitative
test for, 310–311, 311f
Biohazard sign, 91, 92f
Biohazardous materials, spills of,
exposure through, 127–128
Biological hazards, in microbiology
laboratory, exposure control
methods in, protection
against, 388, 389t
Biological variations, 260
Biological waste materials, disposal
of, 97, 98f
Biology, molecular, 57
advances in, 15
Blood
cyanmethemoglobin in, quantitative
determination of, 345
exposure to, postexposure treatment
for, 132
Blood banking, 81–82, 415–431.
See also Immunohematology
(blood banking)
Blood Borne Pathogens Standard, of
OSHA, 131
Blood cell counts. See also specific
types, e.g., White blood cell
(WBC) count
SI units in, examples of, 215, 215t
Blood components, centrifugation
and separation of, 281–282
Blood grouping, direct
slide method in, 424–426, 425f.
See also Immunohematology
(blood banking), direct blood
or forward grouping by slide
method
test tube method in, 422–424.
See also Immunohematology
(blood banking), direct blood
grouping by test tube method
Blood samples
collection of, venipuncture in,
268–269, 270t
drawing of, sequence for, 285f
hemolysis of, 281
obtaining of, during venipuncture,
problems related to, 280–283,
282f, 283t, 284t, 285f
Copyright 2010 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.